Sunshine Biopharma INC. (SBFM) — SEC Filings
Latest SEC filings for Sunshine Biopharma INC.. Recent 10-K filing on Apr 3, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.
View Sunshine Biopharma INC. on SEC EDGAR
Overview
Sunshine Biopharma INC. (SBFM) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-K filed on Apr 3, 2026: Sunshine Biopharma Inc. (SBFM) filed a Annual Report (10-K) with the SEC on April 3, 2026. Sunshine Biopharma Inc. filed its annual report for the fiscal year ending December 31, 2025. The filing is a Form 10-K, indicating a comprehensive overview of the company's financial and operational status. T
Sentiment Summary
Across 1 filings, the sentiment breakdown is: 1 neutral. The dominant filing sentiment for Sunshine Biopharma INC. is neutral.
Filing Type Overview
Sunshine Biopharma INC. (SBFM) has filed 1 10-K with the SEC between Apr 2026.
Recent Filings (1)
-
Sunshine Biopharma Files 2025 Annual Report on Form 10-K
— 10-K · Apr 3, 2026 Risk: low
Sunshine Biopharma Inc. (SBFM) filed a Annual Report (10-K) with the SEC on April 3, 2026. Sunshine Biopharma Inc. filed its annual report for the fiscal year e
Risk Profile
Risk Assessment: Of SBFM's 1 recent filings, 0 were flagged as high-risk, 0 as medium-risk, and 1 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Industry Context
Sunshine Biopharma Inc. operates in the Pharmaceutical Preparations industry, focusing on the development and commercialization of drugs.
Top Tags
10-K (1) · Annual Report (1) · Sunshine Biopharma (1) · Pharmaceuticals (1) · SEC Filing (1)
Key Numbers
- Period of Report: 2025-12-31 — Fiscal Year End
- Filing Date: 2026-04-03 — SEC Filing Date
- iXBRL 10-K Size: 1079582 — FORM 10-K FOR DEC 2025
- Documents: 86 — Total documents in submission
Frequently Asked Questions
What are the latest SEC filings for Sunshine Biopharma INC. (SBFM)?
Sunshine Biopharma INC. has 1 recent SEC filings from Apr 2026, including 1 10-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of SBFM filings?
Across 1 filings, the sentiment breakdown is: 1 neutral. The dominant sentiment is neutral.
Where can I find Sunshine Biopharma INC. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Sunshine Biopharma INC. (SBFM) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Sunshine Biopharma INC.?
Key financial highlights from Sunshine Biopharma INC.'s most recent 10-K include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for SBFM?
The investment thesis for SBFM includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Sunshine Biopharma INC.?
Executive information for Sunshine Biopharma INC. is extracted from SEC filings as they are enriched with AI analysis.
What are the main risk factors for Sunshine Biopharma INC. stock?
Of SBFM's 1 assessed filings, 0 were flagged high-risk, 0 medium-risk, and 1 low-risk.
What are recent predictions and forward guidance from Sunshine Biopharma INC.?
Forward guidance and predictions for Sunshine Biopharma INC. are extracted from SEC filings as they are enriched.